115 related articles for article (PubMed ID: 9146047)
1. [gp-130 related cytokines in mechanisms of myeloma cell growth].
Fukutoku M; Shimizu S
Rinsho Ketsueki; 1997 Apr; 38(4):262-5. PubMed ID: 9146047
[No Abstract] [Full Text] [Related]
2. GP130 cytokines, interferon, survival and proliferation of human myeloma cells.
Klein B
Eur Cytokine Netw; 1997 Sep; 8(3):323. PubMed ID: 9346376
[No Abstract] [Full Text] [Related]
3. [Myeloma cell growth and interleukin 6].
Takahashi T
Nihon Naika Gakkai Zasshi; 1995 Jul; 84(7):1122-6. PubMed ID: 7561370
[No Abstract] [Full Text] [Related]
4. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
5. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
Gadó K; Domján G; Hegyesi H; Falus A
Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
[TBL] [Abstract][Full Text] [Related]
6. IL-6-receptor-mediated growth inhibition by all-trans retinoic acid but not by interferon-alpha in human myeloma cells.
Pulkki K; Neva M; Koskela K; Ollikainen H; Remes K; Pelliniemi TT
Ann N Y Acad Sci; 1995 Jul; 762():457-8. PubMed ID: 7668556
[No Abstract] [Full Text] [Related]
7. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction.
Ogata A; Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
Blood; 1994 Nov; 84(9):3040-6. PubMed ID: 7949175
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
Treon SP; Anderson KC
Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
[TBL] [Abstract][Full Text] [Related]
10. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
Klein B
Semin Hematol; 1995 Jan; 32(1):4-19. PubMed ID: 7878477
[No Abstract] [Full Text] [Related]
11. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of B cell modulation.
Matsuda T; Yamasaki K; Taga T; Hirano T; Kishimoto T
Int Rev Immunol; 1989; 5(2):97-109. PubMed ID: 8691054
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor.
Hooper WC; Phillips DJ; Evatt BL
Thromb Haemost; 1997 May; 77(5):1014-9. PubMed ID: 9184420
[TBL] [Abstract][Full Text] [Related]
14. [Role of adhesion molecules on pathogenesis of multiple myeloma].
Uchiyama H
Rinsho Ketsueki; 1997 Apr; 38(4):271-4. PubMed ID: 9146049
[No Abstract] [Full Text] [Related]
15. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
16. Is IL-6 both a cytokine and a neurotrophic factor?
Wagner JA
J Exp Med; 1996 Jun; 183(6):2417-9. PubMed ID: 8676061
[No Abstract] [Full Text] [Related]
17. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.
Hideshima T; Chauhan D; Schlossman R; Richardson P; Anderson KC
Oncogene; 2001 Jul; 20(33):4519-27. PubMed ID: 11494147
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
20. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
